202 related articles for article (PubMed ID: 36925262)
21. Molecular Structure of Cefuroxime Axetil Complexes with α-, β-, γ-, and 2-Hydroxypropyl-β-Cyclodextrins: Molecular Simulations and Raman Spectroscopic and Imaging Studies.
Gieroba B; Kalisz G; Sroka-Bartnicka A; Płazińska A; Płaziński W; Starek M; Dąbrowska M
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34063471
[TBL] [Abstract][Full Text] [Related]
22. Study of Candesartan Cilexetil: 2-Hydroxypropyl-β-Cyclodextrin Interactions: A Computational Approach Using Steered Molecular Dynamics Simulations.
Kiriakidi S; Mavromoustakos T
Methods Mol Biol; 2021; 2207():45-70. PubMed ID: 33113127
[TBL] [Abstract][Full Text] [Related]
23. Short Review on the Biological Activity of Cyclodextrin-Drug Inclusion Complexes Applicable in Veterinary Therapy.
Grecu M; Minea B; Foia LG; Bostanaru-Iliescu AC; Miron L; Nastasa V; Mares M
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513437
[TBL] [Abstract][Full Text] [Related]
24. Inclusion complexes of quercetin with three β-cyclodextrins derivatives at physiological pH: spectroscopic study and antioxidant activity.
Liu M; Dong L; Chen A; Zheng Y; Sun D; Wang X; Wang B
Spectrochim Acta A Mol Biomol Spectrosc; 2013 Nov; 115():854-60. PubMed ID: 23892509
[TBL] [Abstract][Full Text] [Related]
25. Cyclodextrin-catalyzed deacetylation of spironolactone is pH and cyclodextrin dependent.
Jarho P; Vander Velde D; Stella VJ
J Pharm Sci; 2000 Feb; 89(2):241-9. PubMed ID: 10688753
[TBL] [Abstract][Full Text] [Related]
26. Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems.
Lahiani-Skiba M; Barbot C; Bounoure F; Joudieh S; Skiba M
Drug Dev Ind Pharm; 2006 Oct; 32(9):1043-58. PubMed ID: 17012117
[TBL] [Abstract][Full Text] [Related]
27. Stability, Antioxidant Activity and Intestinal Permeation of Oleuropein Inclusion Complexes with Beta-Cyclodextrin and Hydroxypropyl-Beta-Cyclodextrin.
Liu H; Luo J; Yang P; Yang X; Yan J; Yao Q
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014317
[TBL] [Abstract][Full Text] [Related]
28. Study on the supramolecular system of meso-tetrakis (4-sulfonatophenyl) porphyrin and cyclodextrins by spectroscopy.
Wang XP; Pan JH; Shuang SM
Spectrochim Acta A Mol Biomol Spectrosc; 2001 Dec; 57(14):2755-62. PubMed ID: 11789876
[TBL] [Abstract][Full Text] [Related]
29. Enhanced solubility of guanosine by inclusion complexes with cyclodextrin derivatives: Preparation, characterization, and evaluation.
Mohandoss S; Atchudan R; Immanuel Edison TNJ; Mandal TK; Palanisamy S; You S; Napoleon AA; Shim JJ; Lee YR
Carbohydr Polym; 2019 Nov; 224():115166. PubMed ID: 31472864
[TBL] [Abstract][Full Text] [Related]
30. Complexation of zolpidem with 2-hydroxypropyl-beta-, methyl-beta-, and 2-hydroxypropyl-gamma-cyclodextrin: effect on aqueous solubility, dissolution rate, and ataxic activity in rat.
Trapani G; Latrofa A; Franco M; Pantaleo MR; Sanna E; Massa F; Tuveri F; Liso G
J Pharm Sci; 2000 Nov; 89(11):1443-51. PubMed ID: 11015689
[TBL] [Abstract][Full Text] [Related]
31. Elucidation of the orientation of selected drugs with 2-hydroxylpropyl-β-cyclodextrin using 2D-NMR spectroscopy and molecular modeling.
Adhikari S; Daftardar S; Fratev F; Rivera M; Sirimulla S; Alexander K; Boddu SHS
Int J Pharm; 2018 Jul; 545(1-2):357-365. PubMed ID: 29747001
[TBL] [Abstract][Full Text] [Related]
32. Influence of preparation method on itraconazole oral solutions using cyclodextrins as complexing agents.
Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
Pharmazie; 2007 Jul; 62(7):510-4. PubMed ID: 17718191
[TBL] [Abstract][Full Text] [Related]
33. Exploring the inclusion interaction of estradiol with β-CD and HP-β-CD with the help of molecular dynamics simulation as well as multi-spectroscopic approaches.
Lin ZY; Wang XX; Kou SB; Shi JH
Spectrochim Acta A Mol Biomol Spectrosc; 2022 Mar; 269():120764. PubMed ID: 34954480
[TBL] [Abstract][Full Text] [Related]
34. Molecular Dynamic Simulation Analysis on the Inclusion Complexation of Plumbagin with β-Cyclodextrin Derivatives in Aqueous Solution.
Jitapunkul K; Toochinda P; Lawtrakul L
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833875
[TBL] [Abstract][Full Text] [Related]
35. Study on vitamin K3-cyclodextrin inclusion complex and analytical application.
Zhenming D; Xiuping L; Guomei Z; Shaomin S; Jinghao P
Spectrochim Acta A Mol Biomol Spectrosc; 2003 Jul; 59(9):2073-9. PubMed ID: 12788460
[TBL] [Abstract][Full Text] [Related]
36. Physicochemical and structural characterization of quercetin-beta-cyclodextrin complexes.
Zheng Y; Haworth IS; Zuo Z; Chow MS; Chow AH
J Pharm Sci; 2005 May; 94(5):1079-89. PubMed ID: 15793810
[TBL] [Abstract][Full Text] [Related]
37. Spectroscopic study and antioxidant properties of the inclusion complexes of rosmarinic acid with natural and derivative cyclodextrins.
Celik SE; Ozyürek M; Tufan AN; Güçlü K; Apak R
Spectrochim Acta A Mol Biomol Spectrosc; 2011 May; 78(5):1615-24. PubMed ID: 21377406
[TBL] [Abstract][Full Text] [Related]
38. Theoretical studies on inclusion complexes of cyclodextrins.
Nagaraju M; Sastry GN
J Phys Chem A; 2009 Aug; 113(34):9533-42. PubMed ID: 19655710
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the complexes of furosemide with 2-hydroxypropyl-beta-cyclodextrin and sulfobutyl ether-7-beta-cyclodextrin.
Spamer E; Müller DG; Wessels PL; Venter JP
Eur J Pharm Sci; 2002 Sep; 16(4-5):247-53. PubMed ID: 12208454
[TBL] [Abstract][Full Text] [Related]
40. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.
Chi L; Liu R; Guo T; Wang M; Liao Z; Wu L; Li H; Wu D; Zhang J
Int J Pharm; 2015 Feb; 479(2):349-56. PubMed ID: 25575474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
